Mesoblast (ASX:MSB) today announced that the United States Food and Drug Administration (FDA) has granted Fast Track designation for remestemcel-L in the treatment of acute respiratory distress syndrome (ARDS) due to Covid-19 infection..
Fast Track designation is granted if a therapy demonstrates the potential to address unmet medical needs for a serious or life-threatening disease.
ARDS is the primary cause of death in patients with Covid-19.
Shares in Mesoblast (ASX:MSB) are trading 0.3 per cent lower at $20.23.
13 Apr 2021 - Payment solutions provider Zip Co (ASX:Z1P) has reported March quarter revenue of over $114 million, indicating an 80 per cent rise year on year.
13 Sep 2019 - The ACCC has issued a draft determination proposing to authorise Virgin Australia (ASX:VAH) to more closely cooperate with Virgin Atlantic on flights between Australia and the UK and Ireland, via Hong Kong, Los Angeles and any other future mutual connecting points.
24 Mar 2021 - Santos, (ASX:STO) as operator of the Barossa joint venture, has awarded the contract for the construction, connection and operation of the Floating Production, Storage and Offloading vessel to BW Offshore.
25 May 2021 - A snapshot of the companies making headlines for the hour, featuring CIMIC Group (ASX:CIM), TechnologyOne (ASX:TNE) & Pepper Money (ASX:PPM).
13 Mar 2020 - Zip Co (ASX:Z1P) report that they have not observed any material impact from coronavirus across its business, though they do believe there will be implications for various parts of the economy.
11 May 2023 - Keith Coughlan, Executive Chair at European Metals, talks with Chapter One’s David Tasker at the recent Future Facing Commodities conference in Singapore.
